Kramer HJ - Search Results

1

Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.

Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I. Rakusan D, et al. Among authors: kramer hj. Am J Physiol Renal Physiol. 2010 Oct;299(4):F758-66. doi: 10.1152/ajprenal.00259.2010. Epub 2010 Jul 28. Am J Physiol Renal Physiol. 2010. PMID: 20668096 Free article.

2

Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.

Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L. Husková Z, et al. Kidney Blood Press Res. 2007;30(1):45-55. doi: 10.1159/000099028. Epub 2007 Jan 25. Kidney Blood Press Res. 2007. PMID: 17259738

3

Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.

Kopkan L, Kramer HJ, Husková Z, Vanourková Z, Bäcker A, Bader M, Ganten D, Cervenka L. Kopkan L, et al. Among authors: kramer hj. J Hypertens. 2004 Apr;22(4):819-25. doi: 10.1097/00004872-200404000-00026. J Hypertens. 2004. PMID: 15126925

4

Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.

Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L. Vanecková I, et al. Among authors: kramer hj. Kidney Blood Press Res. 2004;27(4):203-10. doi: 10.1159/000079865. Epub 2004 Jul 20. Kidney Blood Press Res. 2004. PMID: 15273422

5

The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats.

Kopkan L, Kramer HJ, Husková Z, Vanourková Z, Skaroupková P, Thurmová M, Cervenka L. Kopkan L, et al. Among authors: kramer hj. J Hypertens. 2005 Aug;23(8):1531-9. doi: 10.1097/01.hjh.0000174972.46663.5e. J Hypertens. 2005. PMID: 16003180

6

Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.

Husková Z, Kramer HJ, Vanourková Z, Cervenka L. Husková Z, et al. Among authors: kramer hj. J Hypertens. 2006 Mar;24(3):517-27. doi: 10.1097/01.hjh.0000209988.51606.c7. J Hypertens. 2006. PMID: 16467655

7

AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.

Vanourková Z, Kramer HJ, Husková Z, Vanecková I, Opocenský M, Chábová VC, Tesar V, Skaroupková P, Thumová M, Dohnalová M, Mullins JJ, Cervenka L. Vanourková Z, et al. Among authors: kramer hj. J Hypertens. 2006 Dec;24(12):2465-72. doi: 10.1097/01.hjh.0000251909.00923.22. J Hypertens. 2006. PMID: 17082731

8

Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade.

Vanecková I, Kopkan L, Husková Z, Vanourková Z, Schejbalová S, Cervenka L, Kramer HJ. Vanecková I, et al. Among authors: kramer hj. Kidney Blood Press Res. 2007;30(1):38-44. doi: 10.1159/000098869. Epub 2007 Jan 19. Kidney Blood Press Res. 2007. PMID: 17237618

9

AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats.

Vanecková I, Kopkan L, Husková Z, Vanourková Z, Schejbalová S, Cervenka L, Kramer HJ. Vanecková I, et al. Among authors: kramer hj. Vascul Pharmacol. 2007 Jul;47(1):63-7. doi: 10.1016/j.vph.2007.04.005. Epub 2007 Apr 21. Vascul Pharmacol. 2007. PMID: 17521968

10

Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.

Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L. Chábová VC, et al. Among authors: kramer hj. Vascul Pharmacol. 2007 Aug-Sep;47(2-3):145-59. doi: 10.1016/j.vph.2007.05.005. Epub 2007 Jun 2. Vascul Pharmacol. 2007. PMID: 17604232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page